What was Spectral Medical’s price range in the past 12 months?
Spectral Medical lowest stock price was $0.17 and its highest was $0.50 in the past 12 months.
What is Spectral Medical’s market cap?
Currently, no data Available
When is Spectral Medical’s upcoming earnings report date?
Spectral Medical’s upcoming earnings report date is May 10, 2024 which is in 22 days.
How were Spectral Medical’s earnings last quarter?
Spectral Medical released its earnings results on Mar 28, 2024. The company reported -$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.022.
Spectral Medical does not currently pay dividends.
What is Spectral Medical’s EPS estimate?
Spectral Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spectral Medical have?
Spectral Medical has 278,576,260 shares outstanding.
What happened to Spectral Medical’s price movement after its last earnings report?
Spectral Medical reported an EPS of -$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Spectral Medical?
Currently, no hedge funds are holding shares in EDTXF
Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. Its products include Endotoxin Activity Assay (EAA), Toraymyxin, and proprietary reagents. The EAA is use for the diagnostic of endotoxin activity in human whole blood. The Toraymyxin is a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. The company was founded on July 29, 1991 and is headquartered in Toronto, Canada.